Department of Public Laboratory,
National Clinical Research Center for Cancer,
Key Laboratory of Cancer Prevention and Therapy of Tianjin,
Tianjin's Clinical Research Center for Cancer,
Department of Public Laboratory, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin's Clinical Research Center for Cancer
Yuguo Song is a clinical doctor and professor specialized in Occupational Medicine & Clinical Toxicology. He works as a chief-physician and an associate director at the Department of Occupational Medicine & Clinical Toxicology, Beijing Chaoyang Hospital, Capital Medical University (Beijing, China). He received his B.S degree in clinical medicine from the University of Tsingdao Medical College, Shandong Province in 1990, and then he got his MD and Ph.D degree in Capital Medical University. He is the recipient of several research achievement awards including Wu Zhizhong Prize in occupational medicine (China) and International Travel Award from the American Academy of Clinical Toxicology. He ever worked as a visiting scholar in 2010 at West Virginia University, USA. His research focus is clinical toxicology, nanotoxicology, metal toxicology and occupational lung diseases.
1. Cao W, Zhou Y, Niu Y, Zhu X, Song Y, Guo R. Quantitative analysis of hepatic toxicity in rats induced by inhalable silica nanoparticles using acoustic radiation force imaging. J Ultrasound Med. 2017,36(9) :1829-1839.
2. Zhu X, Cao W, Chang B, Zhang L, Qiao P, Li X, Si L, Niu Y, Song Y . Polyacrylate/nanosilica causes pleural and pericardial effusion, and pulmonary fibrosis and granuloma in rats similar to those observed in exposed workers. Int J Nanomedicine 2016;11:1593-605.
3.Niu YM, Zhu XL, Chang B, Tong ZH, Cao W, Qiao PH, Zhang LY, Zhao J, Song YG. Nanosilica and polyacrylate/nanosilica: a comparative study of acute toxicity. Biomed Res Int. 2016. 2016: 9353275.
4. Song Y, Li X, Wang L, Rojanasakul Y, Castranova V, Li H, Ma J. Nanomaterials in humans: identification, characteristics, and potential damage. Toxicol Pathol. 2011;39(5):841-849.
5. Song Y, Tang S. Nanoexposure, unusual diseases, and new health and safety concerns. TheScientificWorldJOURNAL. 2011, 11: 1821–1828.
6. Song Y, Du X, Hao F, Gu X, Zhang Z, Zhang S, Li C, Li H, Ma J. Immunosuppressive therapy of cyclosporin A for severe benzene-induced haematopoietic disorders and a 6-month follow-up. Chem Biol Interact. 2010;186(1):96-102.
7. Song Y, Li X, Du X. Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma. Eur Respir J. 2009; 34(3):559-567.
Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells.
Oncotarget Oct, 2015 | Pubmed ID: 26307676
Tyr23 phosphorylation of Anxa2 enhances STAT3 activation and promotes proliferation and invasion of breast cancer cells.
Breast cancer research and treatment Jul, 2017 | Pubmed ID: 28470457
Rack1 mediates tyrosine phosphorylation of Anxa2 by Src and promotes invasion and metastasis in drug-resistant breast cancer cells.
Breast cancer research : BCR May, 2019 | Pubmed ID: 31113450
Rack1 mediates Src binding to drug transporter P-glycoprotein and modulates its activity through regulating Caveolin-1 phosphorylation in breast cancer cells.
Cell death & disease May, 2019 | Pubmed ID: 31113938
SHP2 promotes proliferation of breast cancer cells through regulating Cyclin D1 stability the PI3K/AKT/GSK3β signaling pathway.
Cancer biology & medicine Aug, 2020 | Pubmed ID: 32944401
A GLUT1 inhibitor-based probe significantly ameliorates the sensitivity of tumor detection and diagnostic imaging.
Chemical communications (Cambridge, England) Jun, 2021 | Pubmed ID: 33959731
A GLUT1 inhibitor-based fluorogenic probe for Warburg effect-targeted drug screening and diagnostic imaging of hyperglycolytic cancers.
Analytica chimica acta Jul, 2021 | Pubmed ID: 34049629
An Unrevealed Molecular Function of Corannulene Buckybowl Glycoconjugates in Selective Tumor Annihilation by Targeting the Cancer-Specific Warburg Effect.
Advanced science (Weinheim, Baden-Wurttemberg, Germany) Apr, 2022 | Pubmed ID: 35253390
Anticancer effects of metformin in experimental animal models of different types of cancer: a systematic review and meta-analysis.
Laboratory animal research Jul, 2022 | Pubmed ID: 35854362
Direct and indirect damage zone of radiofrequency ablation in porcine lumbar vertebra.
Frontiers in oncology , 2023 | Pubmed ID: 36910648
Fructose promotes angiogenesis by improving vascular endothelial cell function and upregulating VEGF expression in cancer cells.
Journal of experimental & clinical cancer research : CR Jul, 2023 | Pubmed ID: 37507736
Fructose-Induced mTORC1 Activation Promotes Pancreatic Cancer Progression through Inhibition of Autophagy.
Cancer research Dec, 2023 | Pubmed ID: 37738413
Colorectal cancer mouse metastasis model combining bioluminescent and micro-computed tomography imaging for monitoring the effects of 5-fluorouracil treatment.
Translational cancer research Oct, 2023 | Pubmed ID: 37969373
Discovery of the Next-Generation Platinum-Based Anticancer Agents for Combating Oxaliplatin-Induced Drug Resistance.
Journal of medicinal chemistry Jun, 2024 | Pubmed ID: 38845105
Annexin A2: the feasibility of being a therapeutic target associated with cancer metastasis and drug resistance in cancer microenvironment.
Discover oncology Dec, 2024 | Pubmed ID: 39692932
Metabolic dysfunction-associated steatotic liver disease and cancer risk: A cohort study.
Diabetes, obesity & metabolism Jan, 2025 | Pubmed ID: 39781580
Xiangqin Zhao1,
Xinbo Gao1,
Wenwen Yu2,
Yi Lu1,
Xuesong Li1,
Lu Tan3,
Xiubao Ren2,
Yifei Wang1,
Weijie Song4,
Jihui Hao1,
Ying Ma1
1Department of Pancreatic Cancer, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Key Laboratory of Digestive Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital,
2Department of Immunology and Biotherapy, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Immunology and Biotherapy, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital,
3Research Core Facility, School of Basic Medical Sciences, Tianjin Medical University,
4Department of Public Laboratory, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital
ABOUT JoVE
Copyright © 2025 MyJoVE Corporation. All rights reserved